Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracavernosal injection and intraurethral therapy for erectile dysfunction.

S Leungwattanakij1, V Flynn, W J Hellstrom

  • 1Department of Urology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.

The Urologic Clinics of North America
|June 14, 2001
PubMed
Summary

Oral therapies are the first-line treatment for erectile dysfunction due to effectiveness and minimal side effects. Alternative intracavernosal and intraurethral treatments remain valuable options when oral medications are ineffective or contraindicated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic effect of ozone and rutin on adriamycin-induced testicular toxicity in an experimental rat model.

Andrologia·2016
Same author

Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease.

Andrology·2014
Same author

PDE5 inhibitors: considerations for preference and long-term adherence.

International journal of clinical practice·2013
Same author

Adolescent varicocoele management controversies.

Andrology·2012
Same author

Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation.

International journal of impotence research·2012

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Oral therapies are the primary treatment for erectile dysfunction (ED).
  • Intracavernosal and intraurethral treatments are established therapeutic options for ED.
  • The development of novel oral ED treatments continues.

Purpose of the Study:

  • To review the current landscape of ED treatments.
  • To highlight the role of oral, intracavernosal, and intraurethral therapies in ED management.
  • To discuss treatment algorithms and patient selection.

Main Methods:

  • Literature review of existing studies on ED therapies.
  • Analysis of treatment efficacy and side effect profiles.
  • Discussion of clinical guidelines and expert opinions.

Related Experiment Videos

Main Results:

  • Oral therapies are effective with minimal side effects and are recommended as first-line treatment for ED.
  • Intracavernosal and intraurethral treatments are viable alternatives when oral therapies fail or are contraindicated.
  • Sildenafil demonstrated success in 56-57% of patients who previously failed other ED treatments.

Conclusions:

  • Oral medications, intracavernosal injections, and intraurethral therapies are all essential components of ED treatment.
  • Treatment choice depends on patient factors, including efficacy, side effects, and contraindications.
  • A stepwise approach to ED management ensures optimal patient outcomes.